EAACI Congress 2024
BackAllergoOncology
Friday 31 May, 12:00 PM -
13:00 PM Valencia, Spain
Poster Zone
Thematic Poster Session
12:00
"For now we see in a mirror, dimly": monocytosis, eosinophilia, basophilia in pancreatic and breast cancer patients
12:00
Adverse infusion reaction during Amivantamab administration
12:00
C1 inhibitor deficiency: a long road from the diagnosis of possible hereditary angioedema to the diagnosis of splenic marginal zone lymphoma
12:00
Cytokine release syndrome due to intravenous trastuzumab with tolerance of subcutaneous administration
12:00
Desensitization in a patient with carboplatin anaphylaxis and mastocytosis
12:00
Desensitization to Darratumumab and mastocyte cytoreduction in patient with systemic mastocytosis Smouldering and Multiple Myeloma
12:00
Development of caninized anti-PD1 and anti-PD-L1 mAbs with canine constant regions IgG1 and IgG4 for cancer therapy
12:00
Management decisions in 13 patients with hypersensitivity reactions to chemotherapy agents
12:00
Omalizumab to the rescue for severe anaphylaxis in desensitization to carboplatin
12:00
Rapid drug desensitization to taxanes: a descriptive study from Turkey
12:00
Risk Factors in Breakthrough Reactions during Monoclonal Antibody Desensitization
12:00
Successful Rapid Desensitization with Atezolizumab after severe hypersensitivity reation in a patient with small-cell lung metastatic cancer: a case report
12:00
Total serum IgE in pancreatic cancer patients: pilot study
